Summary of Purpose
Study to evaluate the safety and efficacy of intravenous recombinant tissue Plasminogen Activator, alteplase, Actilyse® (rt-PA) (0.9 mg/kg) within 3 hours of symptom onset in acute ischemic strokeRead More →
The following dates are available for this trial. Trial information last updated on 28 August 2014.
|1 Jun 2006||28 Aug 2014||1 Mar 2009||Unavailable||1 Aug 2014||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample